Quick Answer
cbdMD, Inc. reported Cash and Equivalents of $2.26 million for fiscal year 2025.
cbdMD, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $2.26M | -7.8% |
| 2024 | $2.45M | +36.4% |
| 2023 | $1.80M | -73.2% |
| 2022 | $6.72M | -74.6% |
| 2021 | $26.41M | +78.2% |
| 2020 | $14.82M | +216.1% |
| 2019 | $4.69M | +9.5% |
| 2018 | $4.28M | +1406.6% |
| 2017 | $284.2K | +729.7% |
| 2016 | $34.3K | -93.7% |
| 2015 | $546.5K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $3.39M | +72.0% | +49.8% |
| September 30, 2025 | $2.26M | -7.8% | +113.4% |
| June 30, 2025 | $1.06M | -55.8% | -40.0% |
| March 31, 2025 | $1.77M | -16.2% | -10.4% |
| December 31, 2024 | $1.97M | +30.9% | -19.7% |
| September 30, 2024 | $2.45M | +36.4% | +2.4% |
| June 30, 2024 | $2.40M | -15.9% | +13.8% |
| March 31, 2024 | $2.11M | +22.5% | +39.9% |
- cbdMD, Inc. showed a decrease of -7.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2015–2025 period, cbdMD, Inc.’s cash and equivalents has grown by 313.8% (from $546.5 thousand to $2.26 million).
- The most recent figure is from cbdMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: